COVID-19 -- Worldwide/Unknown
Inhaled budesonide, a corticosteroid often used [in asthma], was tied to a shorter recovery time in COVID-19 patients who were at a higher risk of severe infection, according to a study published in The Lancet yesterday [Tue 10 Aug 2021]. The researchers [studied] UK residents 65 or older or who were 50 and older with comorbidities who were enrolled in the larger PRINCIPLE trial. Patients were unwell with suspected COVID-19 for up to 14 days (median, 6 days), and were randomized to budesonide
Read more about it at HealthMap Global Disease Alerts via http://healthmap.org/ln.php?8590939&promed&0
No comments:
Post a Comment